Good Economics

Good Economics

The February Data Dump

Grab Bag of Metrics from the Epstein Files, the Olympics, State of the Union, Documentaries Narrated by David Attenborough, Cost of Insulin, War with Iran and More.

Mark G. Sheppard's avatar
Mark G. Sheppard
Feb 27, 2026
∙ Paid

This article is a grab bag of data across different topics. It collects numbers and basic claims from various places and puts them in one place for easy comparison. The point is readability and quick sense making, not perfect completeness or a single unified dataset.

Epstein Files

The first section has data on the Epstein files and the reported number of name mentions in those materials. News reports often use vague terms instead of exact counts, so those terms get converted into simple approximate numbers. These are not exact totals, and different reports may be counting different document sets or using different counting rules. For consistency, vague terms get rounded into easy buckets, for example several becomes 10, just to keep the math simple. However, the numbers for notable figures, like President Trump, do have exact figures.

The State of the Union

The State of the Union made the news for it’s historic length, but what received less attention was the topics covered in that time. This textual analysis of the full transcript shows a heavy emphasis on American greatness and national pride, with 86 keyword hits accounting for 26.5 percent of all mentions. Immigration and border security comes next with 25 hits, followed by economy jobs and employment with 19, and crime and public safety with 18. Foreign policy themes appear but at lower levels, with Iran and nuclear threat at 16, Russia and Ukraine war at 5, and China and geopolitics at 1. Cost of living and housing both register 12 hits, while topics like election integrity, healthcare, and fentanyl sit in the mid single digits.

The Doomsday Clock

The Doomsday Clock is now closer to midnight than at any point in its recorded history, and the long run pattern is unmistakable. After periods of relative distance in earlier decades, the trend since the 2010s has been steadily downward, with each adjustment pushing the clock toward a smaller and smaller buffer of safety. The recent readings sit near the bottom of the entire series, signaling a judgment that overall global risk has intensified rather than eased.

Share

In recent years, the forces driving that shift have been a mix of nuclear, geopolitical, and systemic risks piling on top of each other. The return of major power conflict and heightened nuclear rhetoric has raised the perceived probability of escalation, while arms control frameworks have weakened and modernization of nuclear forces has continued. Alongside that, climate change has moved from a future threat to a present multiplier of instability, and new technologies have added uncertainty through cyber risks, misinformation, and the potential for rapid crisis dynamics. The combined effect is a world seen as more tightly coupled, more volatile, and more capable of cascading failure, which is why the clock has been set closer to midnight than ever before.

The Price of Insulin

The price of insulin is one of the most visible examples of a long running affordability fight in American healthcare. For decades the series is relatively flat, then the curve turns sharply upward in the 2000s and especially through the 2010s, reaching levels that made a century old drug feel like a luxury good. That run up became a national political issue because insulin is not optional, it is a maintenance drug, and higher prices translate quickly into rationing, medical risk, and financial strain for millions of households.

The rise is generally explained by a mix of market structure and pricing mechanics rather than a single cost shock. A small number of manufacturers dominated the market, product tweaks and brand switching helped keep prices elevated, and the rebate system between drugmakers, pharmacy benefit managers, and insurers created incentives for higher list prices even when net prices moved differently. In recent years, prices have fallen more noticeably because of policy pressure and market changes stacking together, including price caps for some patients, larger rebates and negotiated discounts, and more aggressive competition from bio-similars and lower list price versions. The result is a late period decline that reflects both political scrutiny and a gradual shift toward cheaper options, even though access and out of pocket costs can still vary widely depending on insurance and pharmacy channel.

War with Iran

According to political betting market data on Iran, the rising probabilities of conflict between the United States and Iran is measurable. Tensions tends to flare when rhetoric and signaling harden at the same time that the underlying disputes stay unresolved. The main drivers are familiar, the nuclear program and verification fights, regional proxy conflict and retaliation cycles, attacks on shipping and energy infrastructure, and domestic political incentives on both sides that reward toughness. When a president repeatedly emphasizes Iran in major remarks, it can amplify perceptions of escalation risk, even if policy is still ambiguous, because markets and observers start pricing not only stated intentions but also the chance of miscalculation.

User's avatar

Continue reading this post for free, courtesy of Mark G. Sheppard.

Or purchase a paid subscription.
© 2026 Mark G. Sheppard · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture